13,452
Views
79
CrossRef citations to date
0
Altmetric
Review

TRPA1 as a therapeutic target for nociceptive pain

, , &
Pages 997-1008 | Received 15 Jun 2020, Accepted 23 Aug 2020, Published online: 11 Sep 2020

References

  • Nilius B, Appendino G, Owsianik G. The transient receptor potential channel TRPA1: from gene to pathophysiology. Pflugers Arch. 2012;464:425–458.
  • Clapham DE, Runnels LW, Strübing C. The TRP ion channel family. Nat Rev Neurosci. 2001;2:387–396.
  • Wu L-J, Sweet T-B, Clapham DE. International union of basic and clinical pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family. Pharmacol Rev. 2010;62:381–404.
  • Palmer CP, Zhou XL, Lin J, et al. A TRP homolog in Saccharomyces cerevisiae forms an intracellular Ca2+-permeable channel in the yeast vacuolar membrane. Proc Natl Acad Sci U S A. 2001;98:7801–7805.
  • Logashina YA, Korolkova YV, Kozlov SA, et al. TRPA1 channel as a regulator of neurogenic inflammation and pain: structure, function, role in pathophysiology, and therapeutic potential of ligands. Biochem. 2019;84:101–118. Pleiades Publishing.
  • Nilius B, Owsianik G, Voets T, et al. Transient receptor potential cation channels in disease. Physiol Rev. 2007;87:165–217.
  • Cheng W, Sun C, Zheng J. Heteromerization of TRP channel subunits: extending functional diversity. Protein Cell. 2010;1:802–810. Higher Education Press.
  • Moran MM, McAlexander MA, Bíró T, et al. Transient receptor potential channels as therapeutic targets. Nat Rev Drug Discov. 2011;10:601–620.
  • Nassini R, Materazzi S, Benemei S, et al. The TRPA1 channel in inflammatory and neuropathic pain and migraine. Rev Physiol Biochem Pharmacol. 2014;167:1–43.
  • Jaquemar D, Schenker T, Trueb B. An ankyrin-like protein with transmembrane domains is specifically lost after oncogenic transformation of human fibroblasts. J Biol Chem. 1999;274:7325–7333.
  • Story GM, Peier AM, Reeve AJ, et al. ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell. 2003;112:819–829.
  • Talavera K, Startek JB, Alvarez-Collazo J, et al. Mammalian Transient Receptor Potential TRPA1 channels: from structure to disease. Physiol Rev. 2020;100:725–803.
  • Zygmunt PM, Högestätt ED. TRPA1. Handb Exp Pharmacol. 2014;222:583–630.
  • Bandell M, Story GM, Hwang SW, et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron. 2004;41:849–857.
  • Kwan KY, Allchorne AJ, Vollrath MA, et al. TRPA1 contributes to cold, mechanical, and chemical nociception but is not essential for hair-cell transduction. Neuron. 2006;50:277–289.
  • Viana F. TRPA1 channels: molecular sentinels of cellular stress and tissue damage. J Physiol. 2016;594:4151–4169.
  • Paulsen CE, Armache J-P, Gao Y, et al. Structure of the TRPA1 ion channel suggests regulatory mechanisms. Nature. 2015;520:511–517.
  • Samad A, Sura L, Benedikt J, et al. The C-terminal basic residues contribute to the chemical- and voltage-dependent activation of TRPA1. Biochem J. 2011;433:197–204.
  • Cvetkov TL, Huynh KW, Cohen MR, et al. Molecular architecture and subunit organization of TRPA1 ion channel revealed by electron microscopy. J Biol Chem. 2011;286:38168–38176.
  • Gaudet R. A primer on ankyrin repeat function in TRP channels and beyond. Mol Biosyst. 2008;4:372.
  • Nilius B, Prenen J, Owsianik G. Irritating channels: the case of TRPA1. J Physiol. 2011;589:1543–1549.
  • Eberhardt MJ, Filipovic MR, Leffler A, et al. Methylglyoxal activates nociceptors through transient receptor potential channel A1 (TRPA1): a possible mechanism of metabolic neuropathies. J Biol Chem. 2012;287:28291–28306.
  • Kádková A, Synytsya V, Krusek J, et al. Molecular basis of TRPA1 regulation in nociceptive neurons. Rev Physiol Res. 2017;66:425–439. Czech Academy of Sciences.
  • Bautista DM, Movahed P, Hinman A, et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc Natl Acad Sci U S A. 2005;102:12248–12252.
  • Ryskamp DA, Witkovsky P, Barabas P, et al. The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells. J Neurosci. 2011;31:7089–7101.
  • Kim YS, Son JY, Kim TH, et al. Expression of transient receptor potential ankyrin 1 (TRPA1) in the rat trigeminal sensory afferents and spinal dorsal horn. J Comp Neurol. 2010;518:687–698.
  • Kim HY, Chung G, Jo HJ, et al. Characterization of dental nociceptive neurons. J Dent Res. 2011;90:771–776.
  • Kobayashi K, Fukuoka T, Obata K, et al. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with Aδ/C-fibers and colocalization with Trk receptors. J Comp Neurol. 2005;493:596–606.
  • Fischer MJM, Balasuriya D, Jeggle P, et al. Direct evidence for functional TRPV1/TRPA1 heteromers. Pflugers Arch Eur J Physiol. 2014;466:2229–2241.
  • Vennekens R, Menigoz A, Nilius B. TRPs in the brain. Rev Physiol Biochem Pharmacol. 2012;163:27–64.
  • Kheradpezhouh E, Choy JMC, Daria VR, et al. TRPA1 expression and its functional activation in rodent cortex. Open Biol. 2017;7:160314.
  • Koch M, Kreutz S, Böttger C, et al. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels. Hippocampus. 2011;21:554–564.
  • Kunert-Keil C, Bisping F, Krüger J, et al. Tissue-specific expression of TRP channel genes in the mouse and its variation in three different mouse strains. BMC Genomics. 2006;7:159.
  • Sagalajev B, Wei H, Chen Z, et al. Oxidative stress in the amygdala contributes to neuropathic pain. Neuroscience. 2018;387:92–103.
  • Shigetomi E, Tong X, Kwan KY, et al. TRPA1 channels regulate astrocyte resting calcium and inhibitory synapse efficacy through GAT-3. Nat Neurosci. 2011;15:70–80.
  • Stokes A, Wakano C, Koblan-Huberson M, et al. TRPA1 is a substrate for de-ubiquitination by the tumor suppressor CYLD. Cell Signal. 2006;18:1584–1594.
  • Werkheiser JL, Rawls SM, Cowan A. Icilin evokes a dose- and time-dependent increase in glutamate within the dorsal striatum of rats. Amino Acids. 2006;30:307–309.
  • Morelli MB, Amantini C, Liberati S, et al. TRP channels: new potential therapeutic approaches in CNS neuropathies. CNS Neurol Disord Drug Targets. 2013;12:274–293.
  • Araújo DSM, Miya-Coreixas VS, Pandolfo P, et al. Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia. Exp Eye Res. 2017;154:116–125.
  • Souza Monteiro de Araújo D, De Logu F, Adembri C, et al. TRPA1 mediates damage of the retina induced by ischemia and reperfusion in mice. Cell Death Dis. 2020;11:633.
  • García-Añoveros J, Duggan A. TRPA1 in auditory and nociceptive organs. In: Liedtke W, Heller S, editors. TRP ion channel funct sens transduct cell signal cascades. Boca Raton (FL): CRC Press/Taylor & Francis; 2007. p. 163–175.
  • Earley S, Gonzales AL, Crnich R. Endothelium-dependent cerebral artery dilation mediated by trpa1 and CA2+-activated K+ channels. Circ Res. 2009;104:987–994.
  • Mukhopadhyay I, Gomes P, Aranake S, et al. Expression of functional TRPA1 receptor on human lung fibroblast and epithelial cells. J Recept Signal Transduct. 2011;31:350–358.
  • Nassini R, Pedretti P, Moretto N, et al. Transient receptor potential ankyrin 1 channel localized to non-neuronal airway cells promotes non-neurogenic inflammation. PLoS One. 2012;7:e42454.
  • Meents JE, Ciotu CI, Fischer MJM. Trpa1: A molecular view. J Neurophysiol. 2019;121:427–443. American Physiological Society.
  • Andrade EL, Meotti FC, Calixto JB. TRPA1 antagonists as potential analgesic drugs. Pharmacol Ther. 2012;133:189–204.
  • Baraldi PG, Preti D, Materazzi S, et al. Transient Receptor Potential Ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J Med Chem. 2010;53:5085–5107.
  • Bellono NW, Kammel LG, Zimmerman AL, et al. UV light phototransduction activates transient receptor potential A1 ion channels in human melanocytes. Proc Natl Acad Sci U S A. 2013;110:2383–2388.
  • Bellono NW, Oancea E. UV light phototransduction depolarizes human melanocytes. Channels (Austin). 2013;7:243–248.
  • Büch TRH, Schäfer EAM, Demmel M-T, et al. Functional expression of the transient receptor potential channel TRPA1, a sensor for toxic lung inhalants, in pulmonary epithelial cells. Chem Biol Interact. 2013;206:462–471.
  • Earley S. TRPA1 channels in the vasculature. Br J Pharmacol. 2012;167:13–22.
  • Oh M-H, Oh SY, Lu J, et al. TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis. J Immunol. 2013;191:5371–5382.
  • Prasad P, Yanagihara AA, Small-Howard AL, et al. Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A. J Immunol. 2008;181:5024–5034.
  • Takizawa M, Harada K, Nakamura K, et al. Transient receptor potential ankyrin 1 channels are involved in spontaneous peptide hormone release from astrocytes. Biochem Biophys Res Commun. 2018;501:988–995.
  • Hamilton NB, Kolodziejczyk K, Kougioumtzidou E, et al. Proton-gated Ca2+-permeable TRP channels damage myelin in conditions mimicking ischaemia. Nature. 2016;529:523–527.
  • De Logu F, Nassini R, Materazzi S, et al. Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice. Nat Commun. 2017;8:1887.
  • De Logu F, Puma SL, Landini L, et al. Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice. J Clin Invest. 2019;129:5424–5441.
  • Bernardini M, Fiorio Pla A, Prevarskaya N, et al. Human transient receptor potential (TRP) channel expression profiling in carcinogenesis. Int J Dev Biol. 2015;59:399–406.
  • Jordt S-E, Bautista DM, Chuang -H-H, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature. 2004;427:260–265.
  • Macpherson LJ, Geierstanger BH, Viswanath V, et al. The pungency of garlic: activation of TRPA1 and TRPV1 in response to allicin. Curr Biol. 2005;15:929–934.
  • Andrè E, Campi B, Materazzi S, et al. Cigarette smoke-induced neurogenic inflammation is mediated by alpha,beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest. 2008;118:2574–2582.
  • Escalera J, Von Hehn CA, Bessac BF, et al. TRPA1 mediates the noxious effects of natural sesquiterpene deterrents. J Biol Chem. 2008;283:24136–24144.
  • Andersson DA, Gentry C, Moss S, et al. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci. 2008;28:2485–2494.
  • Bessac BF, Sivula M, Von Hehn CA, et al. TRPA1 is a major oxidant sensor in murine airway sensory neurons. J Clin Invest. 2008;118:1899–1910.
  • Sawada Y, Hosokawa H, Matsumura K, et al. Activation of transient receptor potential ankyrin 1 by hydrogen peroxide. Eur J Neurosci. 2008;27:1131–1142.
  • Matta JA, Cornett PM, Miyares RL, et al. General anesthetics activate a nociceptive ion channel to enhance pain and inflammation. Proc Natl Acad Sci U S A. 2008;105:8784–8789.
  • Leffler A, Lattrell A, Kronewald S, et al. Activation of TRPA1 by membrane permeable local anesthetics. Mol Pain. 2011;7:62.
  • Fischer MJM, Leffler A, Niedermirtl F, et al. The general anesthetic propofol excites nociceptors by activating TRPV1 and TRPA1 rather than GABAA receptors. J Biol Chem. 2010;285:34781–34792.
  • Fischer M, Carli G, Raboisson P, et al. The interphase of the formalin test. Pain. 2014;155:511–521.
  • Macpherson LJ, Xiao B, Kwan KY, et al. An ion channel essential for sensing chemical damage. J Neurosci. 2007;27:11412–11415.
  • McNamara CR, Mandel-Brehm J, Bautista DM, et al. TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci. 2007;104:13525–13530.
  • Miyamoto T, Dublin AE, Petrus MJ, et al. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One. 2009;4:e7596.
  • Andersson DA, Gentry C, Moss S, et al. Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+. Proc Natl Acad Sci U S A. 2009;106:8374–8379.
  • Hu H, Bandell M, Petrus MJ, et al. Zinc activates damage-sensing TRPA1 ion channels. Nat Chem Biol. 2009;5:183–190.
  • Andersson DA, Gentry C, Light E, et al. Methylglyoxal evokes pain by stimulating TRPA1. PLoS One. 2013;8:e77986.
  • Cao D-S, Zhong L, Hsieh T, et al. Expression of Transient Receptor Potential Ankyrin 1 (TRPA1) and its role in insulin release from rat pancreatic beta cells. PLoS One. 2012;7:e38005. Obukhov AG, editor.
  • Karashima Y, Damann N, Prenen J, et al. Bimodal action of menthol on the transient receptor potential channel TRPA1. J Neurosci. 2007;27:9874–9884.
  • Lee SP, Buber MT, Yang Q, et al. Thymol and related alkyl phenols activate the hTRPA1 channel. Br J Pharmacol. 2008;153:1739–1749.
  • Xu H, Delling M, Jun JC, et al. Oregano, thyme and clove-derived flavors and skin sensitizers activate specific TRP channels. Nat Neurosci. 2006;9:628–635.
  • Talavera K, Gees M, Karashima Y, et al. Nicotine activates the chemosensory cation channel TRPA1. Nat Neurosci. 2009;12:1293–1299.
  • De Petrocellis L, Vellani V, Schiano-Moriello A, et al. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther. 2008;325:1007–1015.
  • Meseguer V, Karashima Y, Talavera K, et al. Transient receptor potential channels in sensory neurons are targets of the antimycotic agent clotrimazole. J Neurosci. 2008;28:576–586.
  • Fajardo O, Meseguer V, Belmonte C, et al. TRPA1 channels: novel targets of 1,4-dihydropyridines. Channels. 2008;2:429–438.
  • Hu H, Tian J, Zhu Y, et al. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs. Pflugers Arch Eur J Physiol. 2010;459:579–592.
  • De Logu F, Li Puma S, Landini L, et al. The acyl-glucuronide metabolite of ibuprofen has analgesic and anti-inflammatory effects via the TRPA1 channel. Pharmacol Res. 2019;142:127–139.
  • Bessac BF, Jordt S-E. Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control. Physiology (Bethesda). 2008;23:360–370.
  • Cavanaugh EJ, Simkin D, Kim D. Activation of transient receptor potential A1 channels by mustard oil, tetrahydrocannabinol and Ca2+ reveals different functional channel states. Neuroscience. 2008;154:1467–1476.
  • Doerner JF, Gisselmann G, Hatt H, et al. Transient receptor potential channel A1 is directly gated by calcium ions. J Biol Chem. 2007;282:13180–13189.
  • Nagata K, Duggan A, Kumar G, et al. Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci. 2005;25:4052–4061.
  • Wang YY, Chang RB, Waters HN, et al. The nociceptor ion channel TRPA1 is potentiated and inactivated by permeating calcium ions. J Biol Chem. 2008;283:32691–32703.
  • Zurborg S, Yurgionas B, Jira JA, et al. Direct activation of the ion channel TRPA1 by Ca2+. Nat Neurosci. 2007;10:277–279.
  • Schmidt M, Dubin AE, Petrus MJ, et al. Nociceptive signals induce trafficking of TRPA1 to the plasma membrane. Neuron. 2009;64:498–509.
  • Benemei S, De Logu F, Li Puma S, et al. The anti-migraine component of butterbur extracts, isopetasin, desensitizes peptidergic nociceptors by acting on TRPA1 cation channel. Br J Pharmacol. 2017;174:2897–2911.
  • Wei H, Karimaa M, Korjamo T, et al. Transient receptor potential ankyrin 1 ion channel contributes to guarding pain and mechanical hypersensitivity in a rat model of postoperative pain. Anesthesiology. 2012;117:137–148.
  • Koivisto A, Hukkanen M, Saarnilehto M, et al. Inhibiting TRPA1 ion channel reduces loss of cutaneous nerve fiber function in diabetic animals: sustained activation of the TRPA1 channel contributes to the pathogenesis of peripheral diabetic neuropathy. Pharmacol Res. 2012;65:149–158.
  • Chen J, Joshi SK, Didomenico S, et al. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. Pain. 2011;152:1165–1172.
  • Klionsky L, Tamir R, Gao BX, et al. Species-specific pharmacology of trichloro(sulfanyl)ethyl benzamides as transient receptor potential ankyrin 1 (TRPA1) antagonists. Mol Pain. 2007;3:39.
  • Mukhopadhyay I, Kulkarni A, Aranake S, et al. Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by pro-tussive agents: GRC 17536 as a promising anti-tussive therapeutic. PLoS One. 2014;9:e97005.
  • Janssen Pharmaceutica NV. Heterocyclic amides as modulators of TRPA1. WO2010141805. 2010.
  • Merck Sharp & Dohme Corp. Novel TRPA1 antagonists. WO2011043954. 2011.
  • Orion Corporation. Phenyl- sulfonyl derivatives as mediators of TRPA1 receptor activity for the treatment of pain. WO2012152983. 2012.
  • EA Pharma Co Ltd. Heterocyclic amide derivative and pharmaceutical product containing same. EP2805718. 2013.
  • Copeland KW, Boezio AA, Cheung E, et al. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools. Bioorganic Med Chem Lett. 2014;24:3464–3468.
  • Rooney L, Vidal A, D’Souza AM, et al. Discovery, optimization, and biological evaluation of 5-(2- (trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists. J Med Chem. 2014;57:5129–5140.
  • Glenmark Pharmaceuticals Ltd. A clinical trial to study the effects GRC 17536 in patients with painful diabetic peripheral neuropathy (Painful extremities due to peripheral nerve damage in diabetic patients). Full Text View - ClinicalTrials.gov.
  • Cubist pharmaceuticals and hydra biosciences announce plans to begin Phase 1 clinical trial for novel TRPA1 modulator to treat acute. Available at: http://hydrabiosciences.com/pdf/press_releases/2012_01_10.pdf [Last accessed 3 August 2020]
  • Hydra biosciences receives approval from health canada to begin Phase 1 trial for HX-100. Available at: http://hydrabiosciences.com/pdf/press_releases/2015_04_14.pdf [Last accessed 3 August 2020]
  • Orion Corporation. Safety, tolerability, pharmacokinetic and pharmacodynamic effects of ODM-108: in healthy male volunteers. Full Text View - ClinicalTrials.gov.
  • Genentech IA. Study of the safety, tolerability, pharmacokinetics and pharmacodynamic effects of single and multiple ascending doses of GDC-0334 and the effect of food on the pharmacokinetics of GDC-0334 in healthy adult participants. Full Text View - ClinicalTrials.
  • Abd-Elsayed A, Deer TR. Different types of pain. Pain. Springer, Cham, 2019;15–16.
  • Haanpää M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain. 2011;152:14–27.
  • Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci. 2009;32:1–32.
  • Woolf CJ. What is this thing called pain? J Clin Invest. 2010;120:3742–3744.
  • Porter J, Turk DC. Management of pain: best of times, worst of times? Clin J Pain. 2001;17:107–109.
  • Sikandar S, Dickenson AH. Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care. 2012;6:17–26.
  • Nicholas M, Vlaeyen JWS, Rief W, et al. The IASP classification of chronic pain for ICD-11: chronic primary pain. Pain. 2019;160:28–37. Lippincott Williams and Wilkins.
  • Dubin AE, Patapoutian A. Nociceptors: the sensors of the pain pathway. J Clin Invest. 2010;120:3760–3772.
  • Vandewauw I, De Clercq K, Mulier M, et al. A TRP channel trio mediates acute noxious heat sensing. Nature. 2018;555:662–666.
  • Karashima Y, Talavera K, Everaerts W, et al. TRPA1 acts as a cold sensor in vitro and in vivo. Proc Natl Acad Sci U S A. 2009;106:1273–1278.
  • Del Camino D, Murphy S, Heiry M, et al. TRPA1 contributes to cold hypersensitivity. J Neurosci. 2010;30:15165–15174.
  • Corey DP, Garcia-Añoveros J, Holt JR, et al. TRPA1 is a candidate for the mechanosensitive transduction channel of vertebrate hair cells. Nature. 2004;432:723–730.
  • Moparthi L, Zygmunt PM. Human TRPA1 is an inherently mechanosensitive bilayer-gated ion channel. Cell Calcium. 2020;91:102255.
  • Bautista DM, Jordt S-E, Nikai T, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell. 2006;124:1269–1282.
  • Petrus M, Peier AM, Bandell M, et al. A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol Pain. 2007;3:40.
  • McGaraughty S, Chu KL, Perner RJ, et al. TRPA1 modulation of spontaneous and mechanically evoked firing of spinal neurons in uninjured, osteoarthritic, and inflamed rats. Mol Pain. 2010;6:6–14.
  • da Costa DSM, Meotti FC, Andrade EL, et al. The involvement of the transient receptor potential A1 (TRPA1) in the maintenance of mechanical and cold hyperalgesia in persistent inflammation. Pain. 2010;148:431–437.
  • Trevisan G, Materazzi S, Fusi C, et al. Novel therapeutic strategy to prevent chemotherapy-induced persistent sensory neuropathy by TRPA1 blockade. Cancer Res. 2013;73:3120–3131.
  • Moilanen LJ, Laavola M, Kukkonen M, et al. TRPA1 contributes to the acute inflammatory response and mediates carrageenan-induced paw edema in the mouse. Sci Rep. 2012;2:380.
  • Bonet IJM, Fischer L, Parada CA, et al. The role of transient receptor potential A 1 (TRPA1) in the development and maintenance of carrageenan-induced hyperalgesia. Neuropharmacology. 2013;65:206–212.
  • Okun A, Liu P, Davis P, et al. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain. 2012;153:924–933.
  • Chen J, Zhang XF, Kort ME, et al. Molecular determinants of species-specific activation or blockade of TRPA1 channels. J Neurosci. 2008;28:5063–5071.
  • Fernandes ES, Russell FA, Spina D, et al. A distinct role for transient receptor potential ankyrin 1, in addition to transient receptor potential vanilloid 1, in tumor necrosis factor α-induced inflammatory hyperalgesia and Freund’s complete adjuvant-induced monarthritis. Arthritis Rheum. 2011;63:819–829.
  • Colloca L, Ludman T, Bouhassira D, et al. Neuropathic pain. Nat Rev Dis Prim. 2017;3:17002.
  • Stavros K, Simpson DM. Understanding the etiology and management of HIV-associated peripheral neuropathy. Curr HIV/AIDS Rep. 2014;11:195–201.
  • Thakur S, Dworkin RH, Haroun OMO, et al. Acute and chronic pain associated with leprosy. Pain. 2015;156:998–1002. Lippincott Williams and Wilkins.
  • Haroutounian S, Nikolajsen L, Bendtsen TF, et al. Primary afferent input critical for maintaining spontaneous pain in peripheral neuropathy. Pain. 2014;155:1272–1279.
  • Siddall PJ, McClelland JM, Rutkowski SB, et al. A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain. 2003;103:249–257.
  • Davies M, Brophy S, Williams R, et al. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006;29:1518–1522.
  • Klit H, Finnerup NB, Andersen G, et al. Central poststroke pain: A population-based study. Pain. 2011;152:818–824.
  • Bennett MI, Rayment C, Hjermstad M, et al. Prevalence and aetiology of neuropathic pain in cancer patients: A systematic review. Pain. 2012;153:359–365.
  • Borsook D. Neurological diseases and pain. Brain. 2011;135:320–344.
  • Watson JC, Sandroni P. Central neuropathic pain syndromes. Mayo Clin Proc. 2016;91:372–385. Elsevier Ltd.
  • Obata K, Katsura H, Mizushima T, et al. TRPA1 induced in sensory neurons contributes to cold hyperalgesia after inflammation and nerve injury. J Clin Invest. 2005;115:2393–2401.
  • Katsura H, Obata K, Mizushima T, et al. Antisense knock down of TRPA1, but not TRPM8, alleviates cold hyperalgesia after spinal nerve ligation in rats. Exp Neurol. 2006;200:112–123.
  • Caspani O, Zurborg S, Labuz D, et al. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One. 2009;4:e7383.
  • Staaf S, Oerther S, Lucas G, et al. Differential regulation of TRP channels in a rat model of neuropathic pain. Pain. 2009;144:187–199.
  • Eid SR, Crown ED, Moore EL, et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol Pain. 2008;4:48.
  • Wei H, Koivisto A, Saarnilehto M, et al. Spinal transient receptor potential ankyrin 1 channel contributes to central pain hypersensitivity in various pathophysiological conditions in the rat. Pain. 2011;152:582–591.
  • Kwan KY, Glazer JM, Corey DP, et al. TRPA1 modulates mechanotransduction in cutaneous sensory neurons. J Neurosci. 2009;29:4808–4819.
  • Kerstein PC, Del Camino D, Moran MM, et al. Pharmacological blockade of TRPA1 inhibits mechanical firing in nociceptors. Mol Pain. 2009;5:19.
  • Zappia KJ, O’Hara CL, Moehring F, et al. Sensory neuron-specific deletion of TRPA1 results in mechanical cutaneous sensory deficits. eNeuro. 2017;4:ENEURO.0069-16.2017.
  • Horváth Á, Tékus V, Boros M, et al. Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice. Arthritis Res Ther. 2016;18:6.
  • Wei H, Hämäläinen MM, Saarnilehto M, et al. Attenuation of mechanical hypersensitivity by an antagonist of the TRPA1 ion channel in diabetic animals. Anesthesiology. 2009;111:147–154.
  • Trevisani M, Siemens J, Materazzi S, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A. 2007;104:13519–13524.
  • Viisanen H, Chapman H, Wei H, et al. Pronociceptive effects induced by cutaneous application of a Transient Receptor Potential Ankyrin 1 (TRPA1) channel agonist methylglyoxal in diabetic animals: comparison with tunicamycin-induced endoplastic reticulum stress - PubMed. J Physiol Pharmacol. 2016;67:587–594.
  • Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017;81:772–781. John Wiley and Sons Inc.
  • Chen Y, Yang C, Wang ZJ. Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience. 2011;193:440–451.
  • Nassini R, Gees M, Harrison S, et al. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain. 2011;152:1621–1631.
  • Breivik H, Cherny N, Collett B, et al. Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009;20:1420–1433.
  • Falk S, Bannister K, Dickenson AH. Cancer pain physiology. Br J Pain. 2014;8:154–162.
  • Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. Pain. 1999;82:263–274.
  • Mantyh WG, Jimenez-Andrade JM, Stake JI, et al. Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience. 2010;171:588–598.
  • Jänig W, Baron R. Complex regional pain syndrome: mystery explained? Lancet Neurol. 2003;2:687–697. Lancet Publishing Group.
  • Antoniazzi CTDD, Nassini R, Rigo FK, et al. Transient receptor potential ankyrin 1 (TRPA1) plays a critical role in a mouse model of cancer pain. Int J Cancer. 2019;144:355–365.
  • Nagakura Y. Challenges in drug discovery for overcoming dysfunctional pain: an emerging category of chronic pain. Expert Opin Drug Discov. 2015;10:1043–1045. Taylor and Francis Ltd.
  • Marone IM, De Logu F, Nassini R, et al. TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice. Brain. 2018;141:2312–2328.
  • Wang S, Brigoli B, Lim J, et al. Roles of TRPV1 and TRPA1 in spontaneous pain from inflamed masseter muscle. Neuroscience. 2018;384:290–299.
  • Liu CC, Zhang XS, Ruan YT, et al. Accumulation of methylglyoxal increases the advanced glycation end-product levels in DRG and contributes to lumbar disk herniation-induced persistent pain. J Neurophysiol. 2017;118:1321–1328.
  • Achenbach J, Rhein M, Gombert S, et al. Childhood traumatization is associated with differences in TRPA1 promoter methylation in female patients with multisomatoform disorder with pain as the leading bodily symptom. Clin Epigenetics. 2019;11:126.
  • Cattaruzza F, Johnson C, Leggit A, et al. Transient receptor potential ankyrin 1 mediates chronic pancreatitis pain in mice. Am J Physiol Gastrointest Liver Physiol. 2013;304:G1002–1012.
  • Yang J, Li Y, Zuo X, et al. Transient receptor potential ankyrin-1 participates in visceral hyperalgesia following experimental colitis. Neurosci Lett. 2008;440:237–241.
  • Engel MA, Leffler A, Niedermirtl F, et al. TRPA1 and substance P mediate colitis in mice. Gastroenterology. 2011;141:1346–1358.
  • Jain P, Materazzi S, De Logu F, et al. Transient receptor potential ankyrin 1 contributes to somatic pain hypersensitivity in experimental colitis. Sci Rep. 2020;10:8632.
  • Balemans D, Aguilera-Lizarraga J, Florens MV, et al. Histamine-mediated potentiation of transient receptor potential (TRP) ankyrin 1 and TRP vanilloid 4 signaling in submucosal neurons in patients with irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2019;316:G338–G349.
  • Edvinsson L. CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment. Br J Clin Pharmacol. 2015;80:193–199.
  • De Logu F, Landini L, Janal MN, et al. Migraine-provoking substances evoke periorbital allodynia in mice. J Headache Pain. 2019;20:18.
  • Benemei S, Fusi C, Trevisan G, et al. The TRPA1 channel in migraine mechanism and treatment. BrJ Pharmacol. 2014;171:2552–2567. John Wiley and Sons Inc.
  • Kunkler PE, Ballard CJ, Oxford GS, et al. TRPA1 receptors mediate environmental irritant-induced meningeal vasodilatation. Pain. 2011;152:38–44.
  • Ashina M, Hansen JM, Dunga Á, et al. Human models of migraine-short-Term pain for long-Term gain. Nat Rev Neurol. 2017;13:713–724. Nature Publishing Group.
  • Koroleva K, Mustafina A, Yakovlev A, et al. Receptor mechanisms mediating the pro-nociceptive action of hydrogen sulfide in rat trigeminal neurons and meningeal afferents. Front Cell Neurosci. 2017;11:226.
  • Gaudet AD, Popovich PG, Ramer MS. Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury. J Neuroinflammation. 2011;8:110.
  • Ramer MS, French GD, Bisby MA. Wallerian degeneration is required for both neuropathic pain and sympathetic sprouting into the DRG. Pain. 1997;72:71–78.
  • Trevisan G, Benemei S, Materazzi S, et al. TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress. Brain. 2016;139:1361–1377.
  • Nassini R, Materazzi S, Vriens J, et al. The “headache tree” via umbellulone and TRPA1 activates the trigeminovascular system. Brain. 2012;135:376–390.
  • De Logu F, De Prá SDT, de David Antoniazzi CT, et al. Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I. Brain Behav Immun. 2020;88:535–546.